减低剂量与标准剂量全身照射在成人急性淋巴细胞白血病异基因造血干细胞移植前的比较
该回顾性研究分析了101例1999至2024年间接受首次异基因造血干细胞移植的成人急性淋巴细胞白血病患者,比较8 Gy与12 Gy分次全身照射预处理。中位随访8.1年,多因素分析显示12 Gy组非复发死亡率显著增高(sHR 5.97,95%CI 1.77-20.15,p=0.004),且未降低复发率。
要点
- 12 Gy全身照射与更高的非复发死亡率相关,且未降低复发率。
- 8 Gy组患者年龄更大、合并症更多、疾病风险更高,但未调整的结局无差异。
- 移植前可测量残留病数据缺乏,限制了对该预后因素的调整。
核心结论
- 在成人ALL首次allo-HSCT前,12 Gy TBI与NRM增加相关,且无证据表明降低复发率。
- 研究结果支持在特定成人ALL患者中前瞻性评估减低剂量TBI。
研究设计与样本
- 回顾性分析101例1999至2024年间接受首次allo-HSCT的成人ALL患者,比较8 Gy与12 Gy分次TBI预处理。
- 采用多因素Fine-Gray模型分析复发和NRM,中位随访8.1年。
主要发现
- 8 Gy组患者年龄更大、合并症负担更重、疾病风险更高,但未调整的NRM、复发率和总生存无差异。
- 多因素分析中,12 Gy TBI与NRM增加相关(sHR 5.97,95%CI 1.77-20.15,p=0.004),且无复发率降低证据。
- 12 Gy TBI与NRM增加的关联在敏感性分析中一致,包括调整移植年份和预处理方案、病因特异性Cox回归和倾向评分重叠加权。
- 12 Gy TBI与总生存较差在多因素模型中的关联在重叠加权后未得到确认。
关键数值与推荐
- 12 Gy TBI组NRM的亚分布风险比5.97(95%CI 1.77-20.15,p=0.004)。
临床怎么用
- 对于选定成人ALL患者,减低剂量(8 Gy)TBI可能是更优选择,但需前瞻性研究验证。
局限性
- 缺乏一致的移植前可测量残留病数据,限制了对该预后因素的调整。
- 回顾性研究设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Comparative data on reduced-dose (8 Gy) versus standard-dose (12 Gy) total body irradiation (TBI) before allogeneic haematopoietic stem cell transplantation (allo-HSCT) for adults with acute lymphoblastic leukaemia (ALL) remain limited. We retrospectively analysed 101 adults undergoing first allo-HSCT between 1999 and 2024 after 8 Gy or 12 Gy fractionated TBI-based conditioning. Relapse and non-relapse mortality (NRM) were analysed using multivariable Fine-Gray models. Median follow-up was 8.1 years. Although the 8 Gy cohort was older, had greater comorbidity burden and a higher-risk disease profile, unadjusted NRM, relapse incidence and overall survival did not differ between groups. In multivariable analyses, 12 Gy TBI was associated with increased NRM (sub-distribution hazard ratio 5.97, 95% confidence interval [CI] 1.77-20.15; p = 0.004) without evidence of reduced relapse incidence. The association between 12 Gy TBI and higher NRM was consistent across sensitivity analyses, including adjustment for transplant year and conditioning regimen, cause-specific Cox regression and propensity score overlap weighting. The association of 12 Gy TBI with inferior overall survival in the multivariable model was not confirmed after overlap weighting. Consistent pre-transplant measurable residual disease data were unavailable, limiting adjustment for this prognostic factor. These findings support prospective evaluation of reduced-dose TBI in selected adults with ALL.
引用
- Gruber I, Edinger M, Poeck H, et al. Reduced-dose versus standard-dose total body irradiation before allogeneic haematopoietic stem cell transplantation in adults with acute lymphoblastic leukaemia. Br J Haematol. 2026. PMID: 42740588. doi:10.1111/bjh.70835
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。